Seer, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Seer, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 10% in 3 years; of every extra $100 of sales, $1,350 became extra profit. Higher than 98% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.5 times its market value (net cash). Higher than 93% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $47 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $63 tied up three years earlier. More money tied up than 90% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-11.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 53% of Healthcare companies in United States.
Cash Locked Ratio
$47For every $100 of sales, $47 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $63 tied up three years earlier.
More money tied up than 90% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$1,350Sales grew 10% in 3 years; of every extra $100 of sales, $1,350 became extra profit.
Higher than 98% of Healthcare companies in United States.
Asset Productivity Ratio
+10% / -39%In 3 years sales changed by +10% while total assets changed by -39%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-17.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 51% of Healthcare companies in United States.
Cash Cushion Ratio
1.5× cashCash, after subtracting all debt, is 1.5 times its market value (net cash).
Higher than 93% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Seer, Inc. made a loss over the last year. Seer, Inc. owes $0.12 for every $1 it owns. Seer, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSeer, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.48The share price is 0.48 times Seer, Inc.'s book value per share, lower than 92% of Healthcare companies in United States.
Market cap
$109 MThe total market value of all of Seer, Inc.'s shares at today's price (share price × number of shares), smaller than 64% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$226 MWhat Seer, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$4.08Net worth divided by the number of shares. The share price of $1.97 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-26.4%Seer, Inc. lost 26.4% of its shareholders' money over the last year, higher than 62% of Healthcare companies in United States.
Owes vs Owns
0.12×Seer, Inc. owes $0.12 for every $1 it owns (low), lower than 84% of Healthcare companies in United States.
Dividend yield
NoneSeer, Inc. does not currently pay a dividend.
Revenue growth
+16%Revenue rose 16% in the year to Dec 2025, and grew 3% a year on average over 3 years.
Profit growth
LossSeer, Inc. made a loss in each of the last two years.
Profit margin
-456.6%Seer, Inc. lost $457 for every $100 of revenue.
Cash vs debt
Net cashSeer, Inc. held $162 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Seer, Inc.: $109 M ÷ $226 M (30 Jun 2026) = 0.5.
What is Seer, Inc.'s return on equity?
Seer, Inc. lost 26.4% of its shareholders' money over the last year, higher than 62% of Healthcare companies in United States.
How much does Seer, Inc. owe compared with what it owns?
Seer, Inc. owes $0.12 for every $1 it owns (low), lower than 84% of Healthcare companies in United States.
Does Seer, Inc. pay a dividend?
No. Seer, Inc. does not currently pay a dividend.
Is Seer, Inc.'s revenue growing?
Revenue rose 16% in the year to Dec 2025, and grew 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.